Microcatheters Market Size
The global microcatheters market is expected to grow steadily from 2023 to 2028. In 2023, the market was worth $874 million. By 2028, it is forecast to be worth $1.142 billion. This represents a compound annual growth rate of 5.5% over the 5-year period.
Advanced healthcare infrastructure, increasing prevalence of chronic diseases, favorable reimbursement policies, technological advancements and research activities, well-established regulatory framework, increasing awareness and adoption of minimally invasive procedures, and presence of key market in developing regions players. The combination of these factors has propelled the growth of the microcatheter market. With ongoing advancements in technology, increased focus on minimally invasive procedures, and a favorable healthcare ecosystem, the market is expected to continue its growth trajectory. However, competition from alternative technologies or treatment modalities, such as drug-eluting stents, drug-coated balloons, or surgical procedure limits the market growth.Advanced healthcare infrastructure, increasing prevalence of chronic diseases, favorable reimbursement policies, technological advancements and research activities, well-established regulatory framework, increasing awareness and adoption of minimally invasive procedures, and presence of key market in developing regions players. The combination of these factors has propelled the growth of the microcatheter market. With ongoing advancements in technology, increased focus on minimally invasive procedures, and a favorable healthcare ecosystem, the market is expected to continue its growth trajectory. However, competition from alternative technologies or treatment modalities, such as drug-eluting stents, drug-coated balloons, or surgical procedure limits the market growth.
DOWNLOAD PDF BROCHURE-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184715728
The global microcatheter market is poised for robust growth over the next several years, driven by rising demand across major application segments and product categories.
Among product types, diagnostic microcatheters are expected to register significant growth through 2028. The development of cutting-edge imaging technologies like intravascular ultrasound (IVUS), optical coherence tomography (OCT), and fractional flow reserve (FFR) has increased the need for specialized diagnostic microcatheters. These are designed to enable delivery of imaging probes into target areas, allowing for enhanced visualization and precision diagnosis. As interventional radiology and cardiology leverage advanced imaging more frequently, the demand for capable and versatile diagnostic microcatheters will rise accordingly.
By application, the oncology segment is likely to account for a major share of the microcatheter market between 2022 and 2028. With cancer prevalence increasing worldwide, the use of interventional oncology techniques involving microcatheters will also grow. Microcatheters enable localized delivery of cancer therapies, embolization agents, and facilitation of image-guided procedures. There is an accelerating trend toward minimally invasive approaches in oncology, with microcatheters allowing precise drug delivery to tumors while minimizing damage to surrounding healthy tissue. They provide benefits like shorter recovery periods and improved quality of life. As interventional radiologists and oncologists collaborate more closely, microcatheter adoption in cancer care will increase further. Their joint expertise promotes innovation in therapies like transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) that depend extensively on microcatheters.
Among product designs, single-lumen microcatheters dominate the current market landscape. In 2022, this segment accounted for over 90% market share, thanks to the versatility single-lumen microcatheters provide across diagnostic imaging, drug delivery, embolization, angioplasty and biopsy procedures. This multi-functionality makes them highly useful to healthcare professionals. Adequate reimbursement coverage for single-lumen microcatheter procedures also fuels segment growth.
Hospitals, surgical centers and specialty clinics are expected to drive the most microcatheter demand through 2028 as provider training and favorable reimbursement support adoption. Emphasis on training clinicians in microcatheter techniques has increased their comfort with these devices in major healthcare settings.
Geographically, Europe is likely to account for a leading share of the global microcatheter market in 2022, fueled by a rapidly aging population and established healthcare systems with positive reimbursement coverage for procedures using these devices. Favorable demographics and policies create a supportive landscape for microcatheter adoption and growth in the region.
Key players operating in the global microcatheter market include Terumo Corporation, Boston Scientific Corporation, and Cook Medical, among others. These companies and new entrants are poised to benefit from the robust growth projected across product segments and applications in this vital medical device market.
DOWNLOAD PDF BROCHURE-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=184715728
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies — helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.